Basket Study (CT-100-002) to Evaluate the Effects of a DiNaMo™ Component Training

Inclusion Criteria: * Meets indication-specific eligibility criteria as reported by the study participant with adequate clinical documentation * Self-reported average pain intensity during the last 7 days of ≥ 3 of 10 on the Numeric rating Scale (NRS scale) associated with the primary indication * Fluent in written and spoken English (confirmed by ability to read and comprehend the informed consent form.) * Willing and able to comply with study protocol and assessments, evidenced by completion of the Screening Survey. * Lives in the United States. * Has an active email address and is willing and able to receive email messages. * Is the sole user of an iPhone with iPhone operating systems (iOS) 14 or later capabilities or a smartphone with an Android operating system (OS) 10 or later capabilities with cellular and/or internet access for the duration of the study period. Exclusion Criteria: * Has a comorbid acute pain condition, such as from current injuries * Participation in a clinical trial (including psychotherapy, mindfulness, cognitive training, or drug treatment) within the last 2 months * Initiation or change in primary disease-specific medication for 30 days prior to entering the study * Self-reported substance use disorder within the past 1 year * Daily use of opioids of 30 MME (Morphine Milligram Equivalents) or more * Substance use disorder within the past 1 year. * Initiation or change in central nervous system-active medication (e.g., antidepressants) during the last 2 months. * Participation in a clinical trial within the last 2 months. * Planning to introduce new therapies or change therapies during the study duration * Visual, dexterity or cognitive deficit so severe that precludes the use of an app per investigator judgment. * Severe psychiatric disorder involving a history of psychosis * Other significant medical condition that may confound the interpretation of findings